News & Events

Recent News View All News

Jul 28, 2021 8:57am EDT

Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir

Jul 22, 2021 9:00am EDT

Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim

Recent Events View IR Calendar

Jul 26, 2021

Todos announces Annual Shareholder Meeting will be held on July 26, 2021. Proxy posted here.

Jul 7, 2021 11:30 am EDT

Emerging Growth Conference

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings